Optio attends Huntington’s Disease Society of America 37th annual convention – Atlanta, June 2022May 11, 2022Optio attends CHDI – February 2022, Palm Springs, USAFebruary 14, 2022Eric Miller appointed as Executive Director of global rare disease advocacy group – March 2020March 9, 2020Optio attends CHDI – February 2020, Palm Springs, USAFebruary 27, 2020Optio attends the Huntington Study Group annual meeting – November 2019, Sacramento, CANovember 27, 2019JP Morgan Healthcare Conference, January 2019; Optio Biopharma Solutions conducts neurodegenerative rare disease asset valuation due diligence and other activitiesJanuary 15, 2019The Huntington’s market heats up – observations as Optio attends the November 2018 HSG congress.November 11, 2018Optio attends Huntington’s Disease Society of America 33rd annual convention – Los Angeles, June 2018June 6, 2018Optio welcomes Ebo Dawson-Andoh; Executive Consultant, Pharma/Healthcare Survey Analyst – January 2018January 15, 2018Optio conducts social worker and caregiver focus group research at a neurological rare disease meeting – Chicago, IL.June 21, 2017 Tweets by OptioBiopharma All new engagements start with a meeting. Let's Meet!